Archangel Investors Limited’s Post

The investment project of NANOTECH SOLUTIONS SL involves different actions in order to start a business activity in a rural environment and related to high technology. Project financed by the European Regional Development Fund (ERDF)

Sharing our second blog in honor of the second day of #BiotechweekBoston. Today's post covers some tips for companies embarking on their first financing round. #wearemorganlewis

OITA Innovation Summit 2023 is driving the conversation on innovation and investment in Ohio. The economic growth in the state is real! A resilient power grid is the backbone of economic development. #OITA Robert J. Kovey Kamran Ali

The Commission adopted today the European Innovation Council (EIC) 2024 work programme. It opens funding opportunities worth over €1.2 billion in 2024. The majority is dedicated to #SMEs and start-ups to develop and scale up “deep tech” innovations in critical fields such as generative #ArtificialIntelligence (AI), space, critical raw materials, semiconductors and quantum technologies. This goes alongside the Commission Decision which completes the restructuring of the EIC Fund, which will receive a capital injection of €585 million to invest in EIC selected companies, leveraging over €2 billion in new investments. https://lnkd.in/eZp38vf4 #EuropeanCommission #FundingOpportunitites

Fresh funding! Weekly update - July 9th, 2024 Welcome to our weekly update of grants and new funding options for European, and UK tech startups! European funding 💰 Tracing of cryptocurrencies transactions related to criminal purposes closing on November 20, 2024- more than 40M€ to fight crime and terrorism. 🔋 Sustainable high-throughput production processes for stable lithium metal anodes for next generation batteries (Batt4EU Partnership) closing on September 5, 2024 - more than 39M€ to fund key solutions for climate, energy and mobility applications. ⚡ Innovative, Community-Integrated PV systems closing on January 21, 2025 - more than 138M€ to fund those activities targeting a sustainable, secure and competitive energy supply. UK funding 💉 Developmental pathway funding scheme: stage one closing on July 17, 2024- £30 million to develop and test novel therapeutics, medical devices, diagnostics and other interventions. ➡ UK-Taiwan CRD 2024 closing on July 17, 2024- £5 to develop innovative proposals with Taiwan. 🏯 Japan-UK joint opportunity in semiconductor research (JST-EPSRC) closing on July 18, 2024- £4M to support research projects in the field of semiconductors. Other interesting updates! Capricorn Partners - new VC fund worth €85M to fund innovative companies that use technology as a competitive advantage. BEKA - new VC fund worth €50M to fund disruptive startups operating across foodtech. IQ Capital Partners - £30m for Seed and Series A companies across all sector verticals. If you want to be up-to-date on funding opportunities, subscribe to our newsletter: https://fundingtrip.com/ #startups #funding Programme Horizon Europe UKRI - Industrial Decarbonisation Challenge (IDC) IQ Capital Beka Finance Capricorn Partners

#HymeUpdate: We got selected for the #EICAccelerator! 🚀   We are happy to share that from a total of 1083 proposals submitted to the European Innovation Council Accelerator funding, we are part of the 42 companies selected. Our application called #ProjectHYSE was approved for receiving €2,5 million in free grant allocation and further access to €15 million in matching equity, which will be matched 1:1 against new equity from external investors that we would welcome over the next 9 months. This represents a massive achievement for us.   "This funding will allow us to fully mature our #moltensalt #thermalenergystorage technology and to continue building our organization so we can fully unlock the commercial pipeline we have already created. We are thankful and proud of the team that worked hard for months to obtain the funding", says Ask Emil Løvschall-Jensen CEO of Hyme.   We look forward to a future where #greensteam for industrial processes and #power generation is available, always 🌎.   Read more about the EIC Accelerator and the companies selected in the link below 👇.

“Let the good times roll again.” Biotech M&A and IPOs are heating up, but private financing is still a tough process in the current market. I am here to help with high quality connections, friends. Let’s do this! 🐍💫🧬 #markettrends #biotech #innovation #medtech #keepgoing #teamwork #venturecapital #jpm2024 #lifesciences

Are your innovation projects getting derailed? There are some common pitfalls with the traditional ‘experts in a room’ approach. In Phuel’s latest post, leading innovation facilitator Ken Allen shares his insights. Check it out here https://lnkd.in/gaWHcbhA. #PhuelInsights #Innovation #Phuel

Hardman & Co publication on Eos Advisory LLP: Eos Innovation Fund The Eos Innovation Fund invests primarily in Scottish-based unquoted science, engineering or technology companies with an impact aim. It focuses on four areas of investment, where it believes it can have the most impact. Its strongest area of dealflow has been in life sciences. The manager arose out of an angel network based in St Andrews and has quickly built both a solid sourcing capacity and multi-stranded support capability. Having only been investing since 2015, the exit track record is inevitably limited, but there is some positive performance in the unrealised portfolio to date. The report goes into details of how the investment process works, sourcing and decision-making, exit strategies, post-investment governance and monitoring, fees and more. It also includes Hardman & Co’s unique fee calculation table, allowing advisors and investors to properly investigate their effect. Read the full report here: https://lnkd.in/eR5Su4Zb #research #investing #eis #seis #taxenhanced #financials #funds

Ventures w/ Jeffrey Low, MD @ Novo Holdings, Growth Investments How are novel AI technologies and the principles of TechBio transforming traditional approaches to life sciences investment and drug discovery? In our latest episode of BIOS Ventures, Jeffrey Low of Novo Holdings shares unparalleled insights into leveraging permanent capital for long-term innovation, and the critical role diversity plays in enriching scientific breakthroughs. We delve into specific examples where these strategies have accelerated the path from lab bench to market, setting new standards for the industry. How do you see AI and TechBio influencing future investment decisions in your field? Tune in below to hear Jeffrey Low's insights on the future of life sciences investing & how Novo is leading the charge in the next advancements of the industry. Watch it here: https://buff.ly/3OVVKko #LifeSciences #AIInnovation #TechBio #StrategicInvestment